New hope for kids with rare low blood sugar disorder: dasiglucagon shows promise in Long-Term trial
NCT ID NCT03941236
First seen Jan 21, 2026 · Last updated May 08, 2026 · Updated 16 times
Summary
This study tests the long-term safety of a drug called dasiglucagon in children with congenital hyperinsulinism, a rare condition causing dangerously low blood sugar. About 42 children who completed earlier trials will receive dasiglucagon as a continuous shot under the skin. The goal is to see if the drug is safe over time and helps reduce the need for extra sugar or surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL HYPERINSULINISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alder Hey Children's Hospital NHS Foundation Trust
Liverpool, United Kingdom
-
Children's Hospital Colorado
Aurora, Colorado, 80045-7106, United States
-
Cook Children's Endocrinology and Diabetes Clinic
Fort Worth, Texas, 76104-2710, United States
-
Great Ormond Street Hospital for Children NHS Foundation Trust
London, United Kingdom
-
Hadassah Medical Center
Jerusalem, 9765422, Israel
-
Manchester University NHS Foundation Trust
Manchester, United Kingdom
-
NHS Greater Glasgow and Clyde
Glasgow, United Kingdom
-
Otto von Guericke University Magdeburg, Department of Pediatrics
Magdeburg, 39120, Germany
-
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
University Hospital Düsseldorf, Department of Pediatrics
Düsseldorf, 40225, Germany
Conditions
Explore the condition pages connected to this study.